Houston student creates innovative mobile medical lab for rapid COVID-19 testing

young innovator

Taft Foley III, an 18-year-old high school senior, co-founded Texas Mobile Medical Labs. Photo courtesy of Texas Mobile

An 18-year old high school senior from the Houston area mobilized his medical knowledge as one of the youngest EMTs in Texas and co-founded a mobile lab which can provide COVID-19 results in 15 minutes.

Texas Mobile Medical Labs was created to counteract testing delays that bogged down how quickly patients received results. The mobile lab currently operates in a van and a tent outside a community center in the Post Oak area for patients who prefer to come to them. For those that can't, the mobile lab can travel to any patient or business location for employee testing in the Houston area after they set up an appointment.

"This summer I become an EMT, training at the Texas EMS Academy in Corpus Christi," says Taft Foley III, co-founder of Texas Mobile Medical Labs. "When I got back to Houston I was asked to take a COVID-19 test, but I was met with a line that wrapped around the entire building and took two hours just to get inside."

According to Foley, that spurred him into finding a better way to get results to people quickly.

"I did my research and found a better alternative to increase testing and reduce waiting times," says Taft. "The antigen test works in 15 minutes, which makes them amenable to point-of-care use. That's when I really got the idea of going out to our patients for the test so that they don't have to leave home."

The tests are performed with a nasal swab, which then detects a viral protein in an actively infected person, giving accurate and fast results.

Antigens are molecules capable of stimulating an immune response. The SARS-CoV-2 that causes COVID-19 has several known antigens including its nucleocapsid phosphoprotein and spike glycoprotein, which are the visible protrusions on its surface.

Antigen tests reveal if a person is currently infected with a pathogen such as the SARS-CoV-2 virus. Once the infection is gone, the antigen disappears.

Although antigen tests typically have lower sensitivity than a traditional PCR test, that detects the virus through its genetic material, they provide tests rapidly and are relatively cheaper to produce.

"Getting this test to as many people as possible as fast as possible is essential," says Taft. "People need to know whether or not they need to stay home and if they're at risk of spreading the virus to others."

The results are sent to patients via text message or email, giving individuals peace of mind quickly if they are not infected and allowing those with COVID-19 to quarantine themselves and those they have exposed.

The test cost ranges from $100 to $150 for individuals, according to their website, depending on if testers would like to go to their tent location or take advantage of their mobile lab. While they currently do not accept insurance, most insurance companies will reimburse some or all of the cost of the test.

You can reach the Texas Mobile Medical lab at (936) 333-3333 if you have COVID-19 symptoms and would like to schedule an appointment for testing.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

UH lands $11.8M for first-of-its-kind early language development study

speech funding

Researchers at the University of Houston have secured an $11.8 million grant from the National Institutes of Health to conduct a first-of-its-kind study of early language development.

Led by Elena Grigorenko, the Hugh Roy and Lillie Cranz Cullen Distinguished Professor of Psychology, and research professor Jack Fletcher, the study will follow 3,600 children aged 18 to 24 months to uncover how language skills develop at this critical stage and why some children experience delays that can influence later growth.

The NIH funding will also support the development of the new national Clinical Research Center on Developmental Language Disorders at UH, which aims to bring experts from psychology, education, health and measurement sciences to study how children learn language.

“This will be the first national study to estimate how common late talking is using a large, representative sample of Houston toddlers,” Grigorenko said in a news release. “By following these children as they grow, we hope to better understand the developmental pathways that can lead to conditions such as developmental language disorder and autism.”

UH’s team will partner with the pediatric clinic network at Texas Children’s Hospital, where children will be screened for early language development, allowing researchers to identify those who show signs of delayed speech. Next, researchers will follow the cohort through early childhood to examine how language abilities evolve and how early delays may lead to later challenges.

The Clinical Research Center on Developmental Language Disorders will be the 14th national research center established at UH, and will include researchers from multiple UH departments, as well as partners at Baylor College of Medicine and the Texas Center for Learning Disorders.

“This level of investment from the National Institutes of Health reflects the significance of this work to address a complex challenge affecting children, families and communities,” Claudia Neuhauser, vice president for research at UH, said in a news release. “By bringing together experts from multiple disciplines and partnering with major health systems across the region, the project reflects our commitment to advancing discoveries that impact our community.”

Rice Alliance names Houston healthtech exec as first head of platform

new hire

The Rice Alliance for Technology and Entrepreneurship has named its first head of platform.

Houston entrepreneur Laura Neder stepped into the newly created role last month, according to an email from Rice Alliance. Neder will focus on building and growing Houston’s Venture Advantage Platform.

The emerging platform, which is being promoted by Rice Alliance and the Ion, aims to connect founders with the "people, capital and expertise they need to scale."

"I’ve spent a lot of time thinking about what it takes to make an innovation ecosystem more navigable, more connected, and more useful for founders," Neder said in a LinkedIn post. "I’m grateful for the opportunity to do that work at Rice Alliance, alongside a team with a long history of supporting entrepreneurship and innovation."

"Houston has the talent, institutions, and industry base to create real advantage for founders," she added. "I’m looking forward to listening, learning, and building stronger pathways across the ecosystem."

Neder most recently served as CEO of Houston-based Careset, where she helped bring the Medicare data startup to commercialization. Prior to that, Neder served as COO of Houston-based telemedicine startup 2nd.MD, which was acquired for $460 million by Accolade in 2021.

"Laura brings a rare combination of founder empathy, operational experience and ecosystem leadership," Rice Alliance shared.

Neder and Rice Alliance also shared that the organization is hiring developers to design the new Venture Advantage Platform. Learn more here.

Elon Musk's SpaceX files initial paperwork to sell shares to the public

Incoming IPO

Elon Musk's space exploration company has filed preliminary paperwork to sell shares to the public, according to two sources familiar with the filing, a blockbuster offering that would likely rank as the biggest ever and could make its founder the world's first trillionaire.

A SpaceX IPO promises to be one of the biggest Wall Street events of the year, with several investment banks lining up to help raise tens of billions to fund Musk's ambitions to set up a base on the moon, put datacenters the size of several football fields in orbit and possibly one day send a man to Mars.

The sources spoke on condition of anonymity because they were not authorized to talk publicly about the confidential registration with the Securities and Exchange Commission.

SpaceX did not respond immediately to a request for comment.

Exactly how much SpaceX plans to raise has not been disclosed but the figure is reportedly as much as $75 billion. At that level, the offering would easily eclipse the $29 billion that Saudi Aramco raised in its IPO in 2019.

The offering, coming possibly in June, could value all the shares of SpaceX at $1.5 trillion, nearly double what the company was valued in December when some minority owners sold their stakes, according to research firm Pitchbook, before an acquisition that increased its size.

Musk owns 42% of the SpaceX now, according to Pitchbook, though that figure will change with the IPO when new owners are issued shares. In any case, he is likely to pierce the trillion dollar mark because he is already close. Forbes magazine estimates Musk's net worth at roughly $823 billion.

In addition to making reusable rockets to hurl astronauts and hardware into orbit, SpaceX owns Starlink, the world’s largest satellite communications company. The company also recently brought under its roof two other Musk businesses, social media platform X, formerly Twitter, and artificial intelligence business, xAI, in a controversial transaction because both the seller and the buyer were controlled by him.

SpaceX has become the biggest commercial launch company in its industry, responsible for sending payloads into orbit for customers across the globe, but has also benefited from big taxpayer spending. That has raised conflicts of interest issues given that Musk was the biggest donor to President Donald Trump's campaign and is still a big backer.

In the past five years, SpaceX won $6 billion in contracts from NASA, the Defense Department and other U.S. government agencies, according to USAspending.gov.

Among current SpaceX owners is Donald Trump Jr, the president's oldest son. He owns a shares through 1789 Capital. That venture capital firm made him a partner shortly after his father won the presidency for a second time and has been buying up federal contractors seeking to win taxpayer money ever since.

The White House and Trump himself have repeatedly denied there are any conflicts of interest between his role as president and his family's businesses.

View All Listings